0.5527
price up icon4.56%   0.0241
after-market Dopo l'orario di chiusura: .55 -0.0027 -0.49%
loading
Precedente Chiudi:
$0.5286
Aprire:
$0.5274
Volume 24 ore:
495.66K
Relative Volume:
0.02
Capitalizzazione di mercato:
$22.46M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+8.37%
1M Prestazione:
-11.61%
6M Prestazione:
-65.67%
1 anno Prestazione:
-89.10%
Intervallo 1D:
Value
$0.5208
$0.565
Intervallo di 1 settimana:
Value
$0.501
$0.565
Portata 52W:
Value
$0.461
$5.1589

Scienture Holdings Inc Stock (SCNX) Company Profile

Name
Nome
Scienture Holdings Inc
Name
Telefono
(800) 261 0281
Name
Indirizzo
20 AUSTIN BLVD., COMMACK
Name
Dipendente
19
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
SCNX's Discussions on Twitter

Confronta SCNX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Pharmaceutical Retailers icon
SCNX
Scienture Holdings Inc
0.5527 21.48M 0 0 0 0.00
Pharmaceutical Retailers icon
HITI
High Tide Inc
2.68 233.46M 376.07M -22.41M 18.73M -0.298
Pharmaceutical Retailers icon
PETS
Petmed Express Inc
3.32 72.02M 270.52M -6.08M 17.42M -0.2944
Pharmaceutical Retailers icon
RDGT
Ridgetech Inc
2.78 51.75M 119.97M -1.45M 632.50K -0.9847
Pharmaceutical Retailers icon
WGRX
Wellgistics Health Inc
0.403 41.45M 28.99M -39.20M -3.34M 0.00
Pharmaceutical Retailers icon
POM
Pomdoctor Ltd Adr
0.3113 40.24M 0 0 0 0.00

Scienture Holdings Inc Borsa (SCNX) Ultime notizie

pulisher
Jan 08, 2026

Activity Recap: How buybacks impact Scienture Holdings Inc. stock value2025 Earnings Impact & Daily Chart Pattern Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Scienture Holdings Inc. stock beat EPS estimatesJobs Report & Weekly Watchlist of Top Performers - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Scienture Holdings Inc. stock resilient to inflation2025 Major Catalysts & Weekly Momentum Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How buybacks impact Scienture Holdings Inc. stock valuePortfolio Update Summary & Weekly Sector Rotation Insights - ulpravda.ru

Jan 08, 2026
pulisher
Jan 07, 2026

Why Scienture Holdings Inc. stock is trending among retail tradersMean Reversion Trades & Explosive Growth Opportunities - ulpravda.ru

Jan 07, 2026
pulisher
Jan 02, 2026

Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 02, 2026
pulisher
Jan 02, 2026

MSN Money - MSN

Jan 02, 2026
pulisher
Dec 31, 2025

Will Scienture Holdings Inc stock beat EPS estimates2025 Pullback Review & Weekly Return Optimization Alerts - moha.gov.vn

Dec 31, 2025
pulisher
Dec 31, 2025

Scienture Holdings, Inc.Common Stock (Nasdaq:SCNX) Stock Quote - FinancialContent

Dec 31, 2025
pulisher
Dec 28, 2025

Scienture Holdings, Inc. (SCNX) - Zacks Investment Research

Dec 28, 2025
pulisher
Dec 23, 2025

Scienture Prepares Launch Of REZENOPY, Its Highest-Strength Naloxone Nasal Spray - Nasdaq

Dec 23, 2025
pulisher
Dec 23, 2025

SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA - The Globe and Mail

Dec 23, 2025
pulisher
Dec 22, 2025

Scienture to launch high-strength naloxone nasal spray in Q2 2026 - Investing.com Nigeria

Dec 22, 2025
pulisher
Dec 22, 2025

Is Scienture Holdings Inc stock near bottom after declineJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - moha.gov.vn

Dec 22, 2025
pulisher
Dec 22, 2025

Scienture (SCNX) Advances with REZENOPY Nasal Spray Launch - GuruFocus

Dec 22, 2025
pulisher
Dec 22, 2025

Scienture to launch high-strength naloxone nasal spray in Q2 2026 By Investing.com - Investing.com South Africa

Dec 22, 2025
pulisher
Dec 22, 2025

Scienture provides update on the commercial launch of Rezenopy - marketscreener.com

Dec 22, 2025
pulisher
Dec 22, 2025

Scienture Provides Update On The Commercial Launch Of Rezenopy - TradingView — Track All Markets

Dec 22, 2025
pulisher
Dec 22, 2025

New 10 mg overdose nasal spray set to reach U.S. market in 2026 - Stock Titan

Dec 22, 2025
pulisher
Dec 20, 2025

Is Scienture Holdings Inc. stock a top momentum playPortfolio Performance Summary & Low Drawdown Investment Strategies - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Will Scienture Holdings Inc. (4E4) stock announce a stock split2025 Retail Activity & Precise Swing Trade Alerts - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

How Scienture Holdings Inc. stock trades during market volatility2025 Technical Overview & Precise Swing Trade Alerts - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Is Scienture Holdings Inc. (4E4) stock included in top ETFs2025 Winners & Losers & Free High Return Stock Watch Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

How Scienture Holdings Inc. stock reacts to inflationary pressuresWeekly Trade Review & Risk Controlled Swing Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Scienture Holdings Inc. stock a good choice for value investorsWeekly Trade Report & Free Weekly Watchlist of Top Performers - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Scienture Holdings Inc. stock positioned for digital transformationTrade Exit Report & Weekly Top Performers Watchlists - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

What analyst consensus implies for Scienture Holdings Inc. (4E4) stockShort Setup & Reliable Breakout Stock Forecasts - DonanımHaber

Dec 19, 2025
pulisher
Dec 14, 2025

Movement Recap: Is Scienture Holdings Inc 4E4 stock included in top ETFsJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn

Dec 14, 2025
pulisher
Dec 14, 2025

Is Scienture Holdings Inc 4E4 stock included in top ETFsJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn

Dec 14, 2025
pulisher
Dec 11, 2025

Scienture, BlinkRx announce strategic collaboration to expand access to Arbli - Yahoo Finance

Dec 11, 2025
pulisher
Dec 10, 2025

Why Is Scienture Stock Gaining Today? - Benzinga

Dec 10, 2025
pulisher
Dec 10, 2025

Scienture and BlinkRx partner to expand access to liquid losartan By Investing.com - Investing.com Australia

Dec 10, 2025
pulisher
Dec 10, 2025

SCNX FinancialsIncome Statement - Quiver Quantitative

Dec 10, 2025
pulisher
Dec 10, 2025

SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - The Manila Times

Dec 10, 2025
pulisher
Dec 10, 2025

Scienture and BlinkRx partner to expand access to liquid losartan - Investing.com India

Dec 10, 2025
pulisher
Dec 10, 2025

Scienture (NASDAQ: SCNX) taps BlinkRx to launch Arbli, first ready-to-use losartan oral suspension in Q1 2026 - Stock Titan

Dec 10, 2025
pulisher
Dec 08, 2025

A significant driver of top-line growth: Scienture Holdings Inc (SCNX) - Setenews

Dec 08, 2025

Scienture Holdings Inc Azioni (SCNX) Dati Finanziari

Non sono disponibili dati finanziari per Scienture Holdings Inc (SCNX). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$0.78
price down icon 4.88%
pharmaceutical_retailers POM
$0.3113
price down icon 7.79%
$0.403
price down icon 0.54%
$2.78
price down icon 1.77%
$3.32
price down icon 1.48%
Capitalizzazione:     |  Volume (24 ore):